Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Hepatology International|May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trialYu Wang, Huifen Wang, Jun Cheng, et al.Hepatology (Baltimore, Md.)|December 28, 2016
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jialing Zhou, Lin Wang, et al.Ebiomedicine|October 1, 2018
Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter studyFuquan Liu, Zhenyuan Ning, Yanna Liu, et al.JHEP Reports : Innovation in Hepatology|October 18, 2021
Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa studyHaiyan Ma, Tien Huey Lim, Apinya Leerapun, et al.Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.Virology Journal|October 30, 2016
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsSong Yang, Huichun Xing, Yuming Wang, et al.Journal of Viral Hepatitis|January 10, 2019
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Yameng Sun, Jialing Zhou, et al.JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.Cell Reports. Medicine|May 2, 2022
An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertensionQian Yu, Yifei Huang, Xiaoguo Li, et al.Pageof 11